Validation of the English and Simplified Mandarin Versions of the Fear of Progression Questionnaire - Short Form in Chinese Cancer Survivors

Overview

Journal BMC Psychol

Publisher Biomed Central

Specialty Psychology

Date 2020 Feb 2

PMID 32005291

Citations 12

Authors

Rathi Mahendran

Jianlin Liu

Sangita Kuparasundram

Konstadina Griva

Affiliations

Soon will be listed here.

Abstract

Background: The fear of illness progression is common amongst those with chronic illnesses including cancers, and contributes to high psychological morbidity. Research in Asia on such fears however, is limited by a paucity of validated measurement instruments. Amongst the many available instruments, the Fear of Progression Questionnaire has a high quality rating, an important consideration in its selection. This study developed a simplified Mandarin version of the Fear of Progression Questionnaire - Short Form (FoP-Q-SF), and validated the English and Mandarin versions for use in Chinese populations.

Methods: The translation to a simplified Mandarin version was through a forward-backward translation with emphasis on conceptual and cultural equivalence. Cancer survivors (N = 341) completed a self-report questionnaire, the Fear of Progression Questionnaire - Short Form, other measures of fear of progression, depression, anxiety, and quality of life. Reliability and criterion validity were assessed, and the factor-structure was replicated with a confirmatory factor analysis.

Results: The Fear of Progression Questionnaire - Short Form demonstrated high internal and test-retest reliability. Criterion validity was also demonstrated through convergent, concurrent and discriminant validity. The factor structure was supported and replicated. The goodness-of-fit indices of the original model indicated some misfit, which could be adequately addressed by freeing five parameters in the error covariance matrix, without changing the one-factor structure.

Conclusions: The Fear of Progression Questionnaire - Short Form is a reliable and valid measure of fear of progression applicable to a mixed-cancer survivor population in Singapore. The simplified Mandarin version of the questionnaire will be useful in other parts of Asia and for Chinese migrants in the West, further extending the use of this questionnaire.

Citing Articles

Latent profile analysis of fear of progression in obstructive sleep apnea hypoventilation syndrome patients: a cross-sectional study.

Ge Y, Ge D, Guo Z, Wang Y, Wang X, Wang C BMC Psychol. 2025; 13(1):217.

PMID: 40057814 PMC: 11889845. DOI: 10.1186/s40359-025-02543-0.

Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity.

Hu D, Li Y, Zhang H, Wang L, Liu W, Yang X World J Gastroenterol. 2025; 31(1):100357.

PMID: 39777240 PMC: 11684183. DOI: 10.3748/wjg.v31.i1.100357.

Correlation among anxiety and depression, fear of disease progression, and social support in coronary heart disease.

Xu Y, Ma H, Liu S, Gong Q World J Psychiatry. 2024; 14(11):1708-1717.

PMID: 39564166 PMC: 11572683. DOI: 10.5498/wjp.v14.i11.1708.

Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.

Zheng M, Wang S, Zhu Y, Wan H Support Care Cancer. 2023; 31(12):630.

PMID: 37843679 DOI: 10.1007/s00520-023-08085-8.

Development of a simplified version of the smoking rationalization belief scale for Chinese male smokers.

Zhang L, Chen H, Mao Y, Zheng S, Zheng P Front Psychiatry. 2023; 14:1044929.

PMID: 36890984 PMC: 9986291. DOI: 10.3389/fpsyt.2023.1044929.

References

Kwakkenbos L, van den Hoogen F, Custers J, Prins J, Vonk M, van Lankveld W . Validity of the Fear of Progression Questionnaire-Short Form in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2012; 64(6):930-4. DOI: 10.1002/acr.21618. View

Hinz A, Mehnert A, Ernst J, Herschbach P, Schulte T . Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer. 2014; 23(6):1579-87. DOI: 10.1007/s00520-014-2516-5. View

Crist J, Grunfeld E . Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2012; 22(5):978-86. DOI: 10.1002/pon.3114. View

Liu J, Mahendran R, Chua S, Lam K, Lim H, Kuparasundram S . Validation of the English and Mandarin versions of the Fear of Cancer Recurrence Inventory in an Asian population. J Health Psychol. 2017; 25(5):617-628. DOI: 10.1177/1359105317727819. View

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J . From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016; 24(8):3265-8. DOI: 10.1007/s00520-016-3272-5. View

Shim E, Shin Y, Oh D, Hahm B . Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry. 2010; 32(2):169-75. DOI: 10.1016/j.genhosppsych.2009.11.017. View

Berg P, Book K, Dinkel A, Henrich G, Marten-Mittag B, Mertens D . [Fear of progression in chronic diseases]. Psychother Psychosom Med Psychol. 2010; 61(1):32-7. DOI: 10.1055/s-0030-1267927. View

Koch L, Jansen L, Brenner H, Arndt V . Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology. 2012; 22(1):1-11. DOI: 10.1002/pon.3022. View

10.

Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S . Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7(3):300-22. DOI: 10.1007/s11764-013-0272-z. View

11.

Mehnert A, Herschbach P, Berg P, Henrich G, Koch U . [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. Z Psychosom Med Psychother. 2006; 52(3):274-88. DOI: 10.13109/zptm.2006.52.3.274. View

12.

Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S . Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005; 58(6):505-11. DOI: 10.1016/j.jpsychores.2005.02.007. View

13.

Northouse L . Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981; 4(3):213-20. View

14.

Fidika A, Herle M, Herschbach P, Goldbeck L . Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis. J Psychosom Res. 2015; 79(1):49-54. DOI: 10.1016/j.jpsychores.2015.02.014. View

15.

Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C . Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2011; 21(6):571-87. DOI: 10.1002/pon.2070. View

16.

Simard S, Savard J . Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2008; 17(3):241-51. DOI: 10.1007/s00520-008-0444-y. View

17.

Mehnert A, Berg P, Henrich G, Herschbach P . Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009; 18(12):1273-80. DOI: 10.1002/pon.1481. View